Opioid ECHO

Prescribers & Dispensers Schedule

This free virtual clinic will meet every Wednesday from 12pm - 1:30pm EST through September 2021.

A special 6 week series addressing Stimulant Use Disorder will begin on February 17, 2021.

The upcoming sessions are listed below. The topics covered in the remaining sessions will vary between cycles based on participant interests.

Case presentations from participants are key parts of an ECHO clinic. You can submit a confidential, de-identified case by using this Qualtrics survey.

Schedule

Date	Topic	Presentation
9/30/2020	Medications used for Alcohol Use Disorder	View
10/7/2020	Legal Issues Related to OUD	View
10/14/2020	[NO SESSION]
10/21/2020	How to treat OUD in patients with Traumatic Brain Injuries	View
10/28/2020	Best Practices for SUD by Managed Care Companies	View
11/4/2020	Treatments for Tobacco Use Disorder	View
11/11/2020	Harm Reduction Strategies	View
11/18/2020	Behavioral Health Interventions	View
11/25/2020	[NO SESSION]
12/2/2020	Peer Recovery Coaching	View
12/9/2020	Addressing Pain Management in OUD Patients	View
12/16/2020	OUD & Suicide Risks	View
1/6/2021	Indiana Recovery Housing Resources	N/A
1/13/2021	Adverse Childhood Experiences	Position Statement
1/20/2021	Pharmacists Role in the Treatment of OUD	View
1/27/2021	Connection of Human Trafficking to SUD	Position Statement
2/3/2021	Treating OUD in Primary Care Offices	View
2/10/2021	Addressing Psychiatric Concerns in Primary Care Offices	View
2/17/2021	General Overview of Stimulant Use Disorder and Affects on the Brain	View
2/24/2021	Pharmacotherapy of Treating Stimulant Use Disorder and Stimulant Withdrawal
3/3/2021	Treatment of Chronic Psychosis from Stimulants & Behavioral Interventions	View
3/10/2021	Acute and Chronic Complications of Methamphetamine Use	View
3/17/2021	Prescription Stimulant Abuse	[Not Available]
3/24/2021	Contingency Management for the Treatment of Methamphetamine Use Disorder	View
3/31/2021	Withdrawal and Cognitive Impairment of Opioid Use Disorder	View
4/7/2021	[No Session]
4/14/2021	Legal Issues Related to OUD	View
4/21/2021	Motivational Interviewing	View
4/28/2021	Harm Reduction Strategies	View
5/5/2021	Psychiatric Co-morbidities	View
5/12/2021	Stigma Reduction
5/19/2021	Overview of Medications used for the Treatment of OUD
5/26/2021	Assessment of OUD in Primary Care Settings
6/2/2021	Long-acting Injectable Buprenorphine
6/9/2021	Induction of Medications to Treat OUD
6/16/2021	How OUD & MAT affects the brain chemistry
6/23/2021	Compliance & Monitoring Patients with OUD
6/30/2021	Resiliency and Provider Self Care

Past Sessions (Feb 2020 - Sept 2020)

Date	Topic	Presentation
February 12	Overview of MAT & Data Waiver	View
February 19	Assessment of OUD	View
February 26	Induction of MAT	View
March 4	How OUD & MAT affect the brain	View
March 11	Drug Testing/Patient agreement/non-compliance	View
March 18	How to Prepare for DEA Audit	View
March 25	SUD and COVID-19	View
April 1	Harm Reduction Strategies	View
April 8	Telehealth	View
April 15	Pharmacists Role in OUD	View
April 22	COVID-19 MAT Prescribing Guidance	View
April 29	ASAM COVID Resources	View
May 6	Methamphetamines	View
May 13	Peer Recovery Network - COVID Resources	View
May 20	Compassionate Weaning of Opioids for Pain	View
May 27	Sleep Hygiene	View
June 3	Common Drug Trends	View
June 10	Anxiety and SUD	View
June 17	Motivational Interviewing 2.0	View
June 24	When and How to Taper Medications for OUD	View
July 1	[No session]
July 8	NAMI Mental Health Resources	View
July 15	Overview of Drug and Specialty Courts	View
July 22	Overview and Induction of Medications used to treat OUD	View
July 29	Long acting injectable Buprenorphine	View
August 5	Treatment of OUD in those with Traumatic Brain Injuries	View
August 12	Integrated Care Approach to treating OUD	View
August 19	Screening for Traumatic Brain Injuries	View
August 26	Compliance and Monitoring Patients on Medicated Assisted Treatment	View
September 2	Overdose Awareness and Prevention	View
September 9	A Case of Family Addiction - Effects on the Child	View
September 16	INSPECT Updates – Indiana’s Prescription Monitoring Program	N/A
September 23	Functional Analysis and other Behavioral Health Screening Tools	View

Past Sessions (Sept 2019 - Feb 2020)

Date	Topic	Presentation
September 25	Overview of MAT & Data Waiver	View
October 2	Assessment of OUD	View
October 9	Induction of MAT	View
October 16	[No clinic scheduled this week]
October 23	Methampetamines	View
October 30	[No clinic scheduled this week]
November 6	Drug Testing/Patient agreement/non-compliance	View
November 13	HIV & Hep C Testing and Screening	View
November 20	Treatment in the Emergency Dept Setting	View
December 4	SBIRT - Screening, Brief Intervention, Referral to Treatment	View
December 11	Indiana Resources	View
December 18	Indiana Rural Health Association Opioid Consortium	View
January 8	CBD & the Endocannabinoid System	View
January 15	Cognitive Behavioral Therapy	View
January 22	Recovery Works	View
January 29	Self Care and Compassion Fatigue	View
February 5	OUD & Suicide	View

Past Sessions (May 2019 - Sept 2019)

Date	Topic	Presentation
May 29	Overview of Medication-Assisted Treatment & Data Waiver	Part 1 Part 2
June 5	Assessing and Diagnosing OUD	View
June 12	Induction to MAT	View
June 19	Drug Testing/Patient Agreements/Non-Compliance	View
June 26	Neurobiology of OUD & MAT	View
July 10	Stigma Reduction	View
July 17	Legal Issued Related to OUD Patients	View
July 24	Peer Recovery Support Services	View
August 7	Harm Reduction Strategies	View
August 14	Tobacco Cessation	View
August 21	OUD in Pregnancy	View
August 28	Addressing Chronic Pain in Patients with OUD	View
September 4	Behavioral Interventions	View
September 11	Co-Occurring Mental Health Conditions	View
September 18	American Society of Addiction Medicine (ASAM) Guidelines	View